[go: up one dir, main page]

WO2008130607A3 - Compositions de cicatrisation contenant des biomatériaux kératiniques - Google Patents

Compositions de cicatrisation contenant des biomatériaux kératiniques Download PDF

Info

Publication number
WO2008130607A3
WO2008130607A3 PCT/US2008/004984 US2008004984W WO2008130607A3 WO 2008130607 A3 WO2008130607 A3 WO 2008130607A3 US 2008004984 W US2008004984 W US 2008004984W WO 2008130607 A3 WO2008130607 A3 WO 2008130607A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions containing
wound healing
healing compositions
containing keratin
keratin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/004984
Other languages
English (en)
Other versions
WO2008130607A2 (fr
Inventor
Dyke Mark E Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wake Forest University Health Sciences
Original Assignee
Wake Forest University Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University Health Sciences filed Critical Wake Forest University Health Sciences
Priority to CN200880020599A priority Critical patent/CN101730540A/zh
Priority to JP2010504088A priority patent/JP5868592B2/ja
Priority to CA2683015A priority patent/CA2683015C/fr
Priority to EP08743024A priority patent/EP2146738A2/fr
Priority to AU2008241396A priority patent/AU2008241396B2/en
Publication of WO2008130607A2 publication Critical patent/WO2008130607A2/fr
Publication of WO2008130607A3 publication Critical patent/WO2008130607A3/fr
Priority to IL201425A priority patent/IL201425A0/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur des préparations kératiniques destinées à être utilisées dans des applications médicales. L'invention porte sur des procédés de traitement des lésions, suivant lesquels des préparations kératiques sont appliquées sur la lésion en une quantité efficace pour le traitement. L'invention porte également sur des procédés de traitement de lésions de brûlure. L'invention porte aussi sur des adjuvants chirurgicaux ou paramédicaux comprenant un substrat avec des préparations kératiques disposées sur celui-ci. L'invention porte également sur des trousses comprenant des dérivés de kératine conditionnés sous une forme stérile.
PCT/US2008/004984 2006-02-17 2008-04-17 Compositions de cicatrisation contenant des biomatériaux kératiniques Ceased WO2008130607A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN200880020599A CN101730540A (zh) 2007-04-17 2008-04-17 含有角蛋白生物材料的伤口愈合组合物
JP2010504088A JP5868592B2 (ja) 2007-04-17 2008-04-17 ケラチンバイオマテリアルを含有する創傷治癒組成物
CA2683015A CA2683015C (fr) 2007-04-17 2008-04-17 Compositions de cicatrisation contenant des biomateriaux keratiniques
EP08743024A EP2146738A2 (fr) 2007-04-17 2008-04-17 Compositions de cicatrisation contenant des biomatériaux kératiniques
AU2008241396A AU2008241396B2 (en) 2006-02-17 2008-04-17 Wound healing compositions containing keratin biomaterials
IL201425A IL201425A0 (en) 2007-04-17 2009-10-11 Wound healing compositions containing keratin biomaterials

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91226507P 2007-04-17 2007-04-17
US60/912,265 2007-04-17

Publications (2)

Publication Number Publication Date
WO2008130607A2 WO2008130607A2 (fr) 2008-10-30
WO2008130607A3 true WO2008130607A3 (fr) 2009-02-26

Family

ID=39876125

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/004984 Ceased WO2008130607A2 (fr) 2006-02-17 2008-04-17 Compositions de cicatrisation contenant des biomatériaux kératiniques

Country Status (7)

Country Link
EP (1) EP2146738A2 (fr)
JP (1) JP5868592B2 (fr)
CN (1) CN101730540A (fr)
AU (1) AU2008241396B2 (fr)
CA (1) CA2683015C (fr)
IL (1) IL201425A0 (fr)
WO (1) WO2008130607A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10434213B2 (en) 2010-03-05 2019-10-08 Wake Forest University Health Sciences Controlled delivery system
CA2818166C (fr) 2010-11-17 2019-04-30 Wake Forest University Health Sciences Compositions keratiniques pour le traitement d'une deficience ou lesion osseuse
CA2845266C (fr) 2011-08-17 2020-07-21 Keranetics Llc Procedes d'extraction de proteines de la keratine
EP2744480B8 (fr) 2011-08-17 2019-06-26 Keratin Biosciences, Inc. Compositions gélifiantes à faible concentration en protéines
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
CN106470649A (zh) * 2014-06-04 2017-03-01 兹姆生物科学公司 用于改善皮肤质量的组合物和方法
JP6637241B2 (ja) * 2015-03-02 2020-01-29 アドバンス株式会社 可溶性ケラテインの製造法
CN106473945A (zh) * 2016-07-21 2017-03-08 北京东方艾美生物技术股份有限公司 一种角蛋白面膜的制备方法
EP3632927A4 (fr) * 2017-05-31 2020-12-30 Little Scientist Co., Ltd. Dérivé de kératine obtenu à haut rendement, et procédé de mise en oeuvre de celui-ci
CN112794894B (zh) * 2019-10-28 2023-09-26 中国医学科学院药物研究所 一种角蛋白bd-17、制法和其药物组合物与用途
CN112724227B (zh) * 2019-10-28 2023-09-26 中国医学科学院药物研究所 一种角蛋白bd-1、制法和其药物组合物与用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
WO2000076437A1 (fr) * 1999-06-11 2000-12-21 Keraplast Technologies, Ltd. Peptide de keratine soluble
US20030228353A1 (en) * 2002-01-28 2003-12-11 Keraplast Technologies, Ltd. Bioactive keratin peptides
WO2007098053A2 (fr) * 2006-02-17 2007-08-30 Wake Forest University Health Sciences Revêtements et implants biomédicaux constitués de biomatériaux de kératine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1213520A (fr) * 1982-03-17 1986-11-04 Abe Widra Copolyelectrolytes biopolymeres hydrophiles, et pansements biodegradables qui les renferment
FR2661414B1 (fr) * 1990-04-25 1995-03-24 Michel Jean Pierre Produit a base de keratines modifiees, son procede de preparation et les applications notamment en medecine humaine ou veterinaire.
US6371984B1 (en) * 1999-09-13 2002-04-16 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6544548B1 (en) * 1999-09-13 2003-04-08 Keraplast Technologies, Ltd. Keratin-based powders and hydrogel for pharmaceutical applications
US6270793B1 (en) * 1999-09-13 2001-08-07 Keraplast Technologies, Ltd. Absorbent keratin wound dressing
DE60331638D1 (de) * 2002-04-10 2010-04-22 Keraplast Tech Ltd Keratin-netzwerke enthaltende wundverbände für gewebedefekte

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
WO2000076437A1 (fr) * 1999-06-11 2000-12-21 Keraplast Technologies, Ltd. Peptide de keratine soluble
US20030228353A1 (en) * 2002-01-28 2003-12-11 Keraplast Technologies, Ltd. Bioactive keratin peptides
WO2007098053A2 (fr) * 2006-02-17 2007-08-30 Wake Forest University Health Sciences Revêtements et implants biomédicaux constitués de biomatériaux de kératine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
19000101, 1 January 1900 (1900-01-01), XP009109568 *

Also Published As

Publication number Publication date
CA2683015C (fr) 2016-11-08
JP2010524943A (ja) 2010-07-22
AU2008241396A1 (en) 2008-10-30
AU2008241396B2 (en) 2014-06-19
CA2683015A1 (fr) 2008-10-30
JP5868592B2 (ja) 2016-02-24
CN101730540A (zh) 2010-06-09
WO2008130607A2 (fr) 2008-10-30
EP2146738A2 (fr) 2010-01-27
IL201425A0 (en) 2010-05-31

Similar Documents

Publication Publication Date Title
WO2008130607A3 (fr) Compositions de cicatrisation contenant des biomatériaux kératiniques
WO2007098114A3 (fr) Compositions contenant des biomatériaux à base de kératine, destinées à induire la coagulation et la guérison
WO2008019127A3 (fr) Pansement solide pour le traitement de lésion tissulaire
WO2011028965A3 (fr) Pansements médicaux antimicrobiens et protégeant les plaies et sites de cathéter
TW200833330A (en) Substituted dihydropyrazolones and their use
WO2011026614A3 (fr) Compositions et procédés destinés à désinfecter des matériaux
WO2009100716A3 (fr) Produits implantables contenant des nanoparticules
EP2283851A3 (fr) Compositions et procédés pour la promotion de l'hémostase et d'autres activités physiologiques
WO2009123720A3 (fr) Procédés et compositions pour des articles médicaux obtenus à partir de composés protéinés
WO2006048829A3 (fr) Preparation de chitine et derives de chitine destines a un usage cosmetique ou therapeutique
AU2007211617A8 (en) Hydrogel
WO2008103690A3 (fr) Prévention et traitement de l'ostéonécrose et de l'ostéoradionécrose de la mâchoire
WO2008151040A3 (fr) Produit médical enrobé d'analgésique
AU2013288664B2 (en) Dressing having the controlled release of active agents
NZ582556A (en) Pharmaceutical composition for treating wounds and related methods
WO2014110353A8 (fr) Substrats biocompatibles liés à un ligand de notch et leur utilisation dans la formation osseuse
WO2018094023A3 (fr) Dipeptides cycliques et cicatrisation
EP3305305A3 (fr) Compositions à base de silicate et procédés de traitement
WO2009106555A3 (fr) Gel de sucralfate sterilise
WO2008027917A3 (fr) Procédé pour congeler des plaquettes sanguines préservant des facteurs de croissance de plaquettes sanguines actifs
WO2006038803A3 (fr) Composition pour le traitement des plaies et des brulures
WO2007022616A8 (fr) Chirurgie au laser hybride ultrarapide et stimulation de facteurs de croissance pour la chirurgie d'ultraprecision et la cicatrisation
AU2013378873B2 (en) Histo-equivalent bioplastic material
WO2007075750A3 (fr) Compositions contenant un extrait de cotinus coggygria et leur utilisation dans le traitement des plaies
WO2008053432A3 (fr) Formulations chromophores destinées à être utilisées dans le soudage au laser de tissus biologiques

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880020599.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08743024

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2683015

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 201425

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2008241396

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2010504088

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008743024

Country of ref document: EP